BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 25903702)

  • 1. Comparison between modified Dixon MRI techniques, MR spectroscopic relaxometry, and different histologic quantification methods in the assessment of hepatic steatosis.
    Kukuk GM; Hittatiya K; Sprinkart AM; Eggers H; Gieseke J; Block W; Moeller P; Willinek WA; Spengler U; Trebicka J; Fischer HP; Schild HH; Träber F
    Eur Radiol; 2015 Oct; 25(10):2869-79. PubMed ID: 25903702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can negligible hepatic steatosis determined by magnetic resonance imaging-proton density fat fraction obviate the need for liver biopsy in potential liver donors?
    Satkunasingham J; Nik HH; Fischer S; Menezes R; Selzner N; Cattral M; Grant D; Jhaveri K
    Liver Transpl; 2018 Apr; 24(4):470-477. PubMed ID: 29080242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of hepatic steatosis and iron content at 3 Tesla: comparison of two-point Dixon, quantitative multi-echo Dixon, and MR spectroscopy.
    Zhan C; Olsen S; Zhang HC; Kannengiesser S; Chandarana H; Shanbhogue KP
    Abdom Radiol (NY); 2019 Sep; 44(9):3040-3048. PubMed ID: 31286208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of multi-echo Dixon sequence in quantification of hepatic steatosis in Chinese children and adolescents.
    Zhao YZ; Gan YG; Zhou JL; Liu JQ; Cao WG; Cheng SM; Bai DM; Wang MZ; Gao FQ; Zhou SM
    World J Gastroenterol; 2019 Mar; 25(12):1513-1523. PubMed ID: 30948914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease.
    Idilman IS; Keskin O; Celik A; Savas B; Elhan AH; Idilman R; Karcaaltincaba M
    Acta Radiol; 2016 Mar; 57(3):271-8. PubMed ID: 25855666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between incidental fat deposition in the liver and pancreas in asymptomatic individuals.
    Aliyari Ghasabeh M; Shaghaghi M; Khoshpouri P; Pan L; Pandy A; Pandy P; Zhong X; Kannengiesser S; Kamel IR
    Abdom Radiol (NY); 2020 Jan; 45(1):203-210. PubMed ID: 31482380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic fat quantification using chemical shift MR imaging and MR spectroscopy in the presence of hepatic iron deposition: validation in phantoms and in patients with chronic liver disease.
    Lee SS; Lee Y; Kim N; Kim SW; Byun JH; Park SH; Lee MG; Ha HK
    J Magn Reson Imaging; 2011 Jun; 33(6):1390-8. PubMed ID: 21591008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial clinical application of modified Dixon with flexible echo times: hepatic and pancreatic fat assessments in comparison with (1)H MRS.
    Livingstone RS; Begovatz P; Kahl S; Nowotny B; Strassburger K; Giani G; Bunke J; Roden M; Hwang JH
    MAGMA; 2014 Oct; 27(5):397-405. PubMed ID: 24306514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI proton density fat fraction is robust across the biologically plausible range of triglyceride spectra in adults with nonalcoholic steatohepatitis.
    Hong CW; Mamidipalli A; Hooker JC; Hamilton G; Wolfson T; Chen DH; Fazeli Dehkordy S; Middleton MS; Reeder SB; Loomba R; Sirlin CB
    J Magn Reson Imaging; 2018 Apr; 47(4):995-1002. PubMed ID: 28851124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo comparison of two-, three- and four-point Dixon techniques for clinical intramuscular fat quantification at 3 T.
    Noble JJ; Keevil SF; Totman J; Charles-Edwards GD
    Br J Radiol; 2014 Apr; 87(1036):20130761. PubMed ID: 24641314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of a three-step magnetic resonance imaging approach for the assessment of hepatic steatosis in an asymptomatic study population.
    Hetterich H; Bayerl C; Peters A; Heier M; Linkohr B; Meisinger C; Auweter S; Kannengießer SA; Kramer H; Ertl-Wagner B; Bamberg F
    Eur Radiol; 2016 Jun; 26(6):1895-904. PubMed ID: 26340812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive quantification of hepatic fat content in healthy dogs by using proton magnetic resonance spectroscopy and dual gradient echo magnetic resonance imaging.
    Chicca FD; Schwarz A; Meier D; Grest P; Liesegang A; Kircher PR
    J Vet Sci; 2018 Jul; 19(4):570-576. PubMed ID: 29486536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproducibility of MRI-determined proton density fat fraction across two different MR scanner platforms.
    Kang GH; Cruite I; Shiehmorteza M; Wolfson T; Gamst AC; Hamilton G; Bydder M; Middleton MS; Sirlin CB
    J Magn Reson Imaging; 2011 Oct; 34(4):928-34. PubMed ID: 21769986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of a high-SNR chemical-shift-encoded MRI with complex reconstruction for proton density fat fraction (PDFF) estimation overall and in the low-fat range.
    Park CC; Hooker C; Hooker JC; Bass E; Haufe W; Schlein A; Covarrubias Y; Heba E; Bydder M; Wolfson T; Gamst A; Loomba R; Schwimmer J; Hernando D; Reeder SB; Middleton M; Sirlin CB; Hamilton G
    J Magn Reson Imaging; 2019 Jan; 49(1):229-238. PubMed ID: 29707848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of Multi-echo Dixon Sequence in Quantification of Hepatic Steatosis.
    Yurdaisik I; Nurili F
    Cureus; 2020 Feb; 12(2):e7103. PubMed ID: 32231898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy and the effect of possible subject-based confounders of magnitude-based MRI for estimating hepatic proton density fat fraction in adults, using MR spectroscopy as reference.
    Heba ER; Desai A; Zand KA; Hamilton G; Wolfson T; Schlein AN; Gamst A; Loomba R; Sirlin CB; Middleton MS
    J Magn Reson Imaging; 2016 Feb; 43(2):398-406. PubMed ID: 26201284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is MR spectroscopy really the best MR-based method for the evaluation of fatty liver in diabetic patients in clinical practice?
    Parente DB; Rodrigues RS; Paiva FF; Oliveira Neto JA; Machado-Silva L; Lanzoni V; Campos CF; Eiras-Araujo AL; do Brasil PE; Garteiser P; Gomes MB; de Mello Perez R
    PLoS One; 2014; 9(11):e112574. PubMed ID: 25426708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliability of ultrasound hepatorenal index and magnetic resonance imaging proton density fat fraction techniques in the diagnosis of hepatic steatosis, with magnetic resonance spectroscopy as the reference standard.
    Tran BV; Ujita K; Taketomi-Takahashi A; Hirasawa H; Suto T; Tsushima Y
    PLoS One; 2021; 16(8):e0255768. PubMed ID: 34383812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of hepatic steatosis: a comparison of the accuracy among multiple magnetic resonance techniques.
    Wu CH; Ho MC; Jeng YM; Hsu CY; Liang PC; Hu RH; Lai HS; Shih TT
    J Gastroenterol Hepatol; 2014 Apr; 29(4):807-13. PubMed ID: 24224538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver fat quantification: Comparison of dual-echo and triple-echo chemical shift MRI to MR spectroscopy.
    Satkunasingham J; Besa C; Bane O; Shah A; de Oliveira A; Gilson WD; Kannengiesser S; Taouli B
    Eur J Radiol; 2015 Aug; 84(8):1452-1458. PubMed ID: 26047820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.